Surrozen director Kutzkey purchases $3.99 million worth of company shares

We just got some big news about Surrozen. On November 13, 2025, a director of the company, Tim Kutzkey, bought roughly US$3.99million worth of Surrozen shares. That kind of move from an insider tends to grab attention. Insider buying often signals that those who know the company best believe in its future. We explore what this could mean for Surrozen, for investors, and for the future of its drug‑development goals.